Replies to post #14486 on Todos Med Ltd (TOMDF)

[JoeForkeyBolo]

At the bottom of Dr. Brady's web site is the following statement:

Medical Disclaimer: The information on DrDavidBrady.com, and related blogs and emails, is provided for informational purposes only and is not intended to replace consultation with a qualified health care professional. It is not intended as medical advice and DOES NOT create a doctor-patient relationship between you and Dr. Brady. It is not intended for use in diagnosing or treating a health problem or disease, or prescribing treatment. Please consult your physician or healthcare professional before taking any medication or nutritional, herbal or homeopathic supplement, or beginning any treatment for any health problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

https://drdavidbrady.com/

This critique is from a doctor (not an MD) who sells supplements and is required by law to make the same disclaimer Todos makes for Tollovid.

Dr. Brady's critique is nothing more than an opinion of a competitor's product, and should be evaluated with that in mind.

You really can't make this stuff up... promoting the critique of a competitor as valid when all of their own products makes the same disclaimer Todos makes.

[delerious1]

$10 a bottle...a bit less than what I figured but no surprise there'

I wonder if there will be a time when TODOS lower the price on their supplement to more realistically reflect the cost .
There is a certain period on a newly developed product where a company has to recover their R&D costs but once that occurs it does well to try to get some volume of product out there and lower margins to a more realistic level with the hope of catching a bigger market. (Unfortunately I cannot reply since this is my only post allowed today LOL)

Now due to the agreement I would imagine all the gross profit from Tollovid goes straight to 3CL Pharma and their employees anyway?

I don't think the R&D costs would be too high on Tollovid and have likely been captured by now, especially if the ingredients are estimated at $10 a bottle. I feel kinda foolish now but it was a good idea at the time and still may come in handy one day